---
document_datetime: 2024-10-29 09:29:55
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/akantior-epar-all-authorised-presentations_en.pdf
document_name: akantior-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.8458617
conversion_datetime: 2025-12-31 01:24:08.630172
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) Number   | (Invented) name   | Strength   | Pharmaceutical Form   | Route of Administration   | Immediate Packaging          | Content (concentration)   | Pack size                                       |
|------------------|-------------------|------------|-----------------------|---------------------------|------------------------------|---------------------------|-------------------------------------------------|
| EU/1/24/1840/001 | AKANTIOR          | 0.8 mg/ml  | Eye drops, solution   | Ocular use                | single-dose container (LDPE) | 0.3 ml                    | 20 single-dose containers                       |
| EU/1/24/1840/002 | AKANTIOR          | 0.8 mg/ml  | Eye drops, solution   | Ocular use                | single-dose container (LDPE) | 0.3 ml                    | 30 single-dose containers                       |
| EU/1/24/1840/003 | AKANTIOR          | 0.8 mg/ml  | Eye drops, solution   | Ocular use                | single-dose container (LDPE) | 0.3 ml                    | 120 (4 x 30) single-dose containers (multipack) |